ArticleScientific reports2021
Introducing the tablet-based Oxford Cognitive Screen-Plus (OCS-Plus) as an assessment tool for subtle cognitive impairments.
Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed, 1 synthesis or guideline pooled it, 57 citations in OpenAlex.
- eHealth tools to assess the neurological function for research, in absence of the neurologist - a systematic review, part I (software).Journal of neurology · 2024Pooled it
- Development and Validation of the IC3: An Online Remote Assessment Technology for Deep Phenotyping and Monitoring of Cognitive Impairment After Stroke.Assessment · 2026Article
- Development and Validity Study of a Mobile Corsi Block Test for Visuospatial Working Memory in Community-Dwelling Older Adults.Brain sciences · 2026Article
- The Queen Square cognitive assessment screen (Q-CAS): normative data and validation in acute stroke.Journal of neurology · 2026Article
- Longitudinal Trajectories of Global and Domain-Specific Cognition After Stroke Using the Oxford Cognitive Screen.Stroke · 2026Article
- Longitudinal stability of cognitive impairments in post-COVID-19 syndrome assessed with the tablet-based Oxford Cognitive Screen-Plus.Scientific reports · 2026Article
- Comparison of the Tele-Oxford Cognitive Screen to a neuropsychological battery in chronic stroke survivors.Journal of neuropsychology · 2026Article
- Functional Needs Assessment Tool for estimating population-level functional difficulties and the need for services and assistive products: pilot testing in Western Uganda.Frontiers in rehabilitation sciences · 2026Article
- The mini-Oxford cognitive screen (Mini-OCS): A very brief cognitive screen for use in chronic stroke.European stroke journal · 2026Article
- Mitigating the impact of motor impairment on self-administered digital tests: a longitudinal cohort study in stroke.EClinicalMedicine · 2025Article
- The mini-Oxford cognitive screen (Mini-OCS): A very brief cognitive screen for use in chronic stroke.European stroke journal · 2025Article
- Post-stroke cognitive impairment: More than a lesion-symptom model.Imaging neuroscience (Cambridge, Mass.) · 2025Article
- Post-stroke sensory hypersensitivity: insights from lesion-symptom and disconnection mapping.Brain communications · 2025Article
- Assessing neurocognitive functioning among adults ageing with and without HIV at the Kenyan Coast: measurement issues and correlates.Frontiers in aging neuroscience · 2025Article
- An iterative approach for estimating domain-specific cognitive abilities from large scale online cognitive data.NPJ digital medicine · 2024Article
- Emotional and cognitive influences on alcohol consumption in middle-aged and elderly Tanzanians: a population-based study.Scientific reports · 2024Article
- Psychometric Evaluation of a Tablet-Based Tool to Detect Mild Cognitive Impairment in Older Adults: Mixed Methods Study.Journal of medical Internet research · 2024Article
- Domain-specific cognitive impairment 6 months after stroke: The value of early cognitive screening.International journal of stroke : official journal of the International Stroke Society · 2024Article
- Long-term psychological outcomes following stroke: the OX-CHRONIC study.BMC neurology · 2023Article
- Using Multiverse Analysis to Highlight Differences in Convergent Correlation Outcomes Due to Data Analytical and Study Design Choices.Assessment · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 4 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Here, we present the Oxford Cognitive Screen-Plus, a computerised tablet-based screen designed to briefly assess domain-general cognition and provide more fine-grained measures of memory and executive function. The OCS-Plus was designed to sensitively screen for cognitive impairments and provide a differentiation between memory and executive deficits. The OCS-Plus contains 10 subtasks and requires on average 24 min to complete. In this study, 320 neurologically healthy ageing participants (age M = 62.66, SD = 13.75) from three sites completed the OCS-Plus. The convergent validity of this assessment was established in comparison to the ACE-R, CERAD and Rey-Osterrieth. Divergent validity was established through comparison with the BDI and tests measuring divergent cognitive domains. Internal consistency of each subtask was evaluated, and test-retest reliability was determined. We established the normative impairment cut-offs for each of the subtasks. Predicted convergent and divergent validity was found, high internal consistency for most measures was also found with the exception of restricted range tasks, as well as strong test-retest reliability, which provided evidence of test stability. Further research demonstrating the use and validity of the OCS-Plus in various clinical populations is required. The OCS-Plus is presented as a standardised cognitive assessment tool, normed and validated in a sample of neurologically healthy participants. The OCS-Plus will be available as an Android App and provides an automated report of domain-general cognitive impairments in executive attention and memory.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.